World's Best Scientists 2026 revealed!
Jose L. Labandeira-Garcia

Jose L. Labandeira-Garcia

D-Index & Metrics

Neuroscience

D-Index
63
Citations
10444
World Ranking
3451
National Ranking
47

Jose L. Labandeira-Garcia publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Jose L. Labandeira-Garcia sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 200 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Jose L. Labandeira-Garcia D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Jose L. Labandeira-Garcia sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 63 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Jose L. Labandeira-Garcia is affiliated with the University of Santiago de Compostela in Spain. Their primary research intersects medicine, neuroscience, and biochemistry, genetics, and molecular biology, with a particular focus on neurology, cellular and molecular neuroscience, molecular biology, physiology, and infectious diseases.

The scientist has contributed significantly to several fields of study, including:

  • Parkinson's Disease Mechanisms and Treatments
  • Receptor Mechanisms and Signaling
  • Nuclear Receptors and Signaling
  • Renin-Angiotensin System Studies
  • Neuroscience and Neuropharmacology Research
  • COVID-19 Clinical Research Studies
  • Neuroinflammation and Neurodegeneration Mechanisms

Jose L. Labandeira-Garcia has published extensively in a variety of scientific venues. The most frequent publication venues include:

  • Antioxidants
  • IBRO Neuroscience Reports
  • bioRxiv (Cold Spring Harbor Laboratory)
  • npj Parkinson's Disease
  • Redox Biology

Their recent papers highlight a focus on both neurodegenerative diseases and the biochemical mechanisms related to COVID-19. Examples include:

  • Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19, 2021, Journal of Autoimmunity
  • Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson's Disease and Adverse Effects of L-DOPA, 2020, Frontiers in Neuroanatomy
  • Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19, 2021, Clinical Science
  • Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of Parkinson's disease, 2021, Redox Biology
  • The intracellular renin-angiotensin system: Friend or foe. Some light from the dopaminergic neurons, 2020, Progress in Neurobiology

Collaboration is a significant aspect of their research, with frequent co-authors including:

  • Ana I. Rodríguez-Pérez
  • Pablo Garrido-Gil
  • Carmen M. Labandeira
  • Rita Valenzuela
  • María A. Pedrosa

The work of Jose L. Labandeira-Garcia spans several important research themes such as the molecular and cellular mechanisms underlying Parkinson's disease, roles of receptor and nuclear receptor signaling pathways, and investigations into the renin-angiotensin system's function in the nervous system.

Their contributions include studies on neuroinflammation, neurodegeneration, and neuropharmacology, integrating these themes with emerging clinical research on COVID-19.

Best Publications

  • Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease.

    Ramón Soto‐Otero;Estefanía Méndez‐Álvarez;Álvaro Hermida‐Ameijeiras;Ana María Muñoz‐Patiño

  • An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism

    G Rozas;M.J Guerra;J.L Labandeira-Garcı́a

  • The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism

    G Rozas;E López-Martı́n;M.J Guerra;J.L Labandeira-Garcı́a

  • Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons

    J. Rodriguez-Pallares;J. A. Parga;A. Muñoz;P. Rey

  • Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration.

    Jose L. Labandeira-Garcia;Ana I. Rodríguez-Perez;Pablo Garrido-Gil;Jannette Rodriguez-Pallares

  • Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS.

    J. Rodriguez-Pallares;P. Rey;J.A. Parga;A. Muñoz

  • The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease.

    Belen Joglar;Jannette Rodriguez-Pallares;Ana Isabel Rodriguez-Perez;Pablo Rey

  • Insulin-Like Growth Factor-1 and Neuroinflammation.

    Jose L. Labandeira-Garcia;Maria A. Costa-Besada;Carmen M. Labandeira;Begoña Villar-Cheda

  • Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease.

    Ramón Soto-Otero;Estefanı́a Méndez-Álvarez;Álvaro Hermida-Ameijeiras;Ana Marı́a López-Real

  • Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease

    Pablo Garrido-Gil;Belen Joglar;Ana I Rodriguez-Perez;Maria J Guerra

  • Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis.

    José L Lanciego;José L Lanciego;Pedro Barroso-Chinea;Pedro Barroso-Chinea;Alberto J Rico;Alberto J Rico;Lorena Conte-Perales;Lorena Conte-Perales

  • Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia

    Gemma Navarro;Dasiel Borroto-Escuela;Edgar Angelats;Íñigo Etayo

  • Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin–angiotensin system in the nigra

    Pablo Garrido-Gil;Rita Valenzuela;Begoña Villar-Cheda;Jose L. Lanciego

  • Effects of aluminum and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: relevance for the pathogenesis of Parkinson's disease.

    Estefanı́a Méndez-Álvarez;Ramón Soto-Otero;Álvaro Hermida-Ameijeiras;Ana Marı́a López-Real

  • Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism.

    A. Lopez-Real;P. Rey;R. Soto-Otero;E. Mendez-Alvarez

  • Brain renin-angiotensin system and dopaminergic cell vulnerability.

    Jose L. Labandeira-García;Pablo Garrido-Gil;Jannette Rodriguez-Pallares;Rita Valenzuela

  • Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration

    Rita Valenzuela;Maria A Costa-Besada;Javier Iglesias-Gonzalez;Emma Perez-Costas

  • Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons.

    P. Rey;A. Lopez-Real;S. Sanchez-Iglesias;A. Muñoz

  • Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation

    Ana I. Rodriguez-Perez;Ana Borrajo;Jannette Rodriguez-Pallares;Maria J. Guerra

  • Involvement of microglial RhoA/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors.

    Begoña Villar-Cheda;Antonio Dominguez-Meijide;Belen Joglar;Ana I. Rodriguez-Perez

  • Sprouting of the serotonergic afferents into striatum after selective lesion of the dopaminergic system by MPTP in adult mice.

    G Rozas;I Liste;M.J Guerra;J.L Labandeira-Garcia

  • Development of intrastriatal striatal grafts and their afferent innervation from the host.

    J.L. Labandeira-Garcia;K. Wictorin;E.T. Cunningham;A. Björklund

  • Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson’s Disease Models

    Pablo Garrido-Gil;Ana I. Rodriguez-Perez;Antonio Dominguez-Meijide;Maria J. Guerra

Frequent Co-Authors

Maria J. Guerra
Maria J. Guerra University of Santiago de Compostela
Rafael Franco
Rafael Franco University of Barcelona
José L. Lanciego
José L. Lanciego University of Navarra
Gemma Navarro
Gemma Navarro University of Barcelona
José López-Barneo
José López-Barneo Spanish National Research Council
Vicent Casadó
Vicent Casadó University of Barcelona
Rosario Moratalla
Rosario Moratalla Spanish National Research Council
Salvador Martinez
Salvador Martinez Miguel Hernandez University
Enric I. Canela
Enric I. Canela University of Barcelona
Isabel Fariñas
Isabel Fariñas University of Valencia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring neuroscience opens doors to a variety of related online degrees and professional careers in the behavioral and mental health fields. Students interested in the fundamentals of brain function and human behavior may benefit from enrolling in psychology degrees online. These programs often provide flexibility and affordability while introducing key neuroscience concepts.

For those wanting to make a difference through counseling or therapy, consider the online master's in social work route or explore lmft online programs that prepare you for licensure as a marriage and family therapist. Both pathways emphasize mental health practice and intervention, grounded in research and clinical knowledge.

If your career goals include advanced clinical roles or specialty areas in mental health care, check out the online psych d programs. Earning a Doctor of Psychology can lead to opportunities in assessment, therapy, and even leadership positions. Each of these online program options can help cultivate robust career pathways for those passionate about neuroscience and its real-world applications.

Best Scientists Citing Jose L. Labandeira-Garcia

Trending Scientists

Recently Published Articles